These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21549125)

  • 1. Preclinical studies of human disease: time to take methodological quality seriously.
    van der Worp HB; Macleod MR
    J Mol Cell Cardiol; 2011 Oct; 51(4):449-50. PubMed ID: 21549125
    [No Abstract]   [Full Text] [Related]  

  • 2. [Preclinical research. Seal of approval translational medicine].
    Hermann S; Pichler B; Kotzerke J
    Nuklearmedizin; 2013 Dec; 52(6):N53-4. PubMed ID: 24337015
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical research: Make mouse studies work.
    Perrin S
    Nature; 2014 Mar; 507(7493):423-5. PubMed ID: 24678540
    [No Abstract]   [Full Text] [Related]  

  • 4. Reverse translation of failed treatments can help improving the validity of preclinical animal models.
    't Hart BA
    Eur J Pharmacol; 2015 Jul; 759():14-8. PubMed ID: 25823810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Animal models: Mouse already being charted gene by gene.
    Brown S
    Nature; 2014 Apr; 508(7496):319. PubMed ID: 24740057
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenges of translational research for analgesics: the state of knowledge needs upgrading and some uncomfortable deficiencies remain to be urgently addressed.
    Quessy SN
    J Pain; 2010 Jul; 11(7):698-700. PubMed ID: 20605748
    [No Abstract]   [Full Text] [Related]  

  • 7. Methodological Rigor in Preclinical Cardiovascular Studies: Targets to Enhance Reproducibility and Promote Research Translation.
    Ramirez FD; Motazedian P; Jung RG; Di Santo P; MacDonald ZD; Moreland R; Simard T; Clancy AA; Russo JJ; Welch VA; Wells GA; Hibbert B
    Circ Res; 2017 Jun; 120(12):1916-1926. PubMed ID: 28373349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The next step in translational research: lessons learned from the first preclinical randomized controlled trial.
    Llovera G; Liesz A
    J Neurochem; 2016 Oct; 139 Suppl 2():271-279. PubMed ID: 26968835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emulating multicentre clinical stroke trials: a new paradigm for studying novel interventions in experimental models of stroke.
    Bath PM; Macleod MR; Green AR
    Int J Stroke; 2009 Dec; 4(6):471-9. PubMed ID: 19930059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical predictors of clinical safety: opportunities for improvement.
    Sistare FD; DeGeorge JJ
    Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standards and Methodological Rigor in Pulmonary Arterial Hypertension Preclinical and Translational Research.
    Provencher S; Archer SL; Ramirez FD; Hibbert B; Paulin R; Boucherat O; Lacasse Y; Bonnet S
    Circ Res; 2018 Mar; 122(7):1021-1032. PubMed ID: 29599278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure drug discovery: scarred or ready for remodeling?
    Plump A; Madwed J
    J Mol Cell Cardiol; 2011 Oct; 51(4):444-8. PubMed ID: 21854785
    [No Abstract]   [Full Text] [Related]  

  • 13. Why clinical translation cannot succeed without failure.
    London AJ; Kimmelman J
    Elife; 2015 Nov; 4():e12844. PubMed ID: 26599839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoform-selective HDAC inhibitors: closing in on translational medicine for the heart.
    McKinsey TA
    J Mol Cell Cardiol; 2011 Oct; 51(4):491-6. PubMed ID: 21108947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selecting promising ALS therapies in clinical trials.
    Glass JD; Benatar M; Polak M
    Neurology; 2007 May; 68(18):1545-6; author reply 1546. PubMed ID: 17470765
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating data from the Investigational Medicinal Product Dossier/investigator's brochure. A new tool for translational integration of preclinical effects.
    van Gerven J; Cohen A
    Br J Clin Pharmacol; 2018 Jul; 84(7):1457-1466. PubMed ID: 29381216
    [No Abstract]   [Full Text] [Related]  

  • 17. Tackling reproducibility in academic preclinical drug discovery.
    Frye SV; Arkin MR; Arrowsmith CH; Conn PJ; Glicksman MA; Hull-Ryde EA; Slusher BS
    Nat Rev Drug Discov; 2015 Nov; 14(11):733-4. PubMed ID: 26388229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preface to the special issue "Novel pharmaconeurogenetic approaches arising from progress in translational genetics".
    Renger JJ; Kern JT
    J Neurogenet; 2011 Dec; 25(4):117-9. PubMed ID: 22074379
    [No Abstract]   [Full Text] [Related]  

  • 19. Mammalian animal models for Duchenne muscular dystrophy.
    Willmann R; Possekel S; Dubach-Powell J; Meier T; Ruegg MA
    Neuromuscul Disord; 2009 Apr; 19(4):241-9. PubMed ID: 19217290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Publication bias in trials other than RCTs].
    Timmer A
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(3):194-200. PubMed ID: 21530909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.